Mendus AB (publ) (IMMU) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.037x

Based on the latest financial reports, Mendus AB (publ) (IMMU) has a cash flow conversion efficiency ratio of -0.037x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-20.80 Million ≈ $-2.24 Million USD) by net assets (Skr565.14 Million ≈ $60.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Mendus AB (publ) market capitalisation for the company's overall valuation and market capitalisation.

Mendus AB (publ) - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how Mendus AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Mendus AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mendus AB (publ) ranked by their cash flow conversion efficiency. See how well can Mendus AB (publ) service its debt to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Karyopharm Therapeutics Inc NASDAQ:KPTI	0.076x
Ozerden Plastik Sanayi IS:OZRDN	0.718x
Gavari Properties SOCIMI S.A. MC:YGAV	N/A
SKILLCAST GROUP LS -001 F:K9I	N/A
JD Sports Fashion PLC LSE:JD	0.285x
Prodways Group SA PA:PWG	0.066x
S&S Power Switchgears Limited NSE:S&SPOWER	-0.163x
KESM Industries Bhd KLSE:9334	0.035x

Annual Cash Flow Conversion Efficiency for Mendus AB (publ) (2010–2025)

The table below shows the annual cash flow conversion efficiency of Mendus AB (publ) from 2010 to 2025. View latest Mendus AB (publ) stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr585.07 Million ≈ $62.96 Million	Skr-81.53 Million ≈ $-8.77 Million	-0.139x	-12.85%
2024-12-31	Skr645.15 Million ≈ $69.43 Million	Skr-79.67 Million ≈ $-8.57 Million	-0.123x	+46.53%
2023-12-31	Skr704.73 Million ≈ $75.84 Million	Skr-162.76 Million ≈ $-17.52 Million	-0.231x	-8.67%
2022-12-31	Skr514.44 Million ≈ $55.36 Million	Skr-109.33 Million ≈ $-11.77 Million	-0.213x	-1.12%
2021-12-31	Skr656.74 Million ≈ $70.68 Million	Skr-138.03 Million ≈ $-14.85 Million	-0.210x	-145.38%
2020-12-31	Skr661.09 Million ≈ $71.14 Million	Skr-56.63 Million ≈ $-6.09 Million	-0.086x	+83.98%
2019-12-31	Skr272.78 Million ≈ $29.36 Million	Skr-145.81 Million ≈ $-15.69 Million	-0.535x	-107.36%
2018-12-31	Skr406.04 Million ≈ $43.70 Million	Skr-104.67 Million ≈ $-11.26 Million	-0.258x	-5.20%
2017-12-31	Skr189.56 Million ≈ $20.40 Million	Skr-46.45 Million ≈ $-5.00 Million	-0.245x	+25.64%
2016-12-31	Skr102.39 Million ≈ $11.02 Million	Skr-33.74 Million ≈ $-3.63 Million	-0.330x	-14.00%
2015-12-31	Skr139.18 Million ≈ $14.98 Million	Skr-40.23 Million ≈ $-4.33 Million	-0.289x	+53.42%
2014-12-31	Skr64.63 Million ≈ $6.95 Million	Skr-40.10 Million ≈ $-4.32 Million	-0.621x	-570.22%
2013-12-31	Skr100.24 Million ≈ $10.79 Million	Skr-9.28 Million ≈ $-998.77K	-0.093x	+68.12%
2012-12-31	Skr24.60 Million ≈ $2.65 Million	Skr-7.15 Million ≈ $-769.03K	-0.290x	+31.50%
2011-12-31	Skr7.63 Million ≈ $820.73K	Skr-3.23 Million ≈ $-347.98K	-0.424x	+0.26%
2010-12-31	Skr3.92 Million ≈ $421.83K	Skr-1.67 Million ≈ $-179.31K	-0.425x	--

About Mendus AB (publ)

ST:IMMU Sweden Biotechnology

Market Cap

$42.60 Million

Skr395.89 Million SEK

Market Cap Rank

#22577 Global

#423 in Sweden

Share Price

Skr6.46

Change (1 day)

+1.89%

52-Week Range

Skr3.96 - Skr7.47

All Time High

Skr737.49